Yokota, Tomoya
Bendell, Johanna
LoRusso, Patricia
Tsushima, Takahiro
Desai, Ved
Kenmotsu, Hirotsugu
Watanabe, Junichiro
Ono, Akira
Murugesan, Bhavani
Silva, Joseph
Naito, Tateaki
Greenberg, Jonathan
Kumar, Prasanna
Wang, Yibin
Jikoh, Takahiro
Shiga, Ryota
Hyman, David M.
Ho, Alan Loh
Spriggs, David R.
Schwartz, Gary K.
Gounder, Mrinal M.
Article History
Received: 21 December 2017
Revised: 4 April 2018
Accepted: 11 April 2018
First Online: 24 May 2018
Competing interests
: The authors declare no competing interests.
: Studies were approved by the Institutional Review Board in Shizuoka Cancer Center (the committee’s reference number: P23-31-23-1-2), Sarah Cannon Research Institute (IRB00001035, IRB00003657, IRB00004920, IRB00006075), Karmanos Cancer Center (068111PH1F), and Memorial Sloan-Kettering Cancer Center (MSK 11-114). Written informed consent in English and Japanese was obtained from all patients prior to enrollment. The study followed the Declaration of Helsinki and good clinical practice guidelines.
: Data generated or analysed during this study are included in this published article and its supplementary information files. Further raw data are available from the authors upon reasonable request and with permission of Daiichi Sankyo Co., Ltd.